Gentamicin Sulphate Prices 2026: Trend, Price Index, Demand, Chart and Forecast
Author : ChemAnalyst Data | Published On : 30 Sep 2026
According to ChemAnalyst, The global Gentamicin Sulphate Prices recorded an upward trend during the second quarter of 2026, with prices increasing across key markets in Asia Pacific (APAC), North America, and Europe. The price movement was primarily shaped by higher production costs, strengthening industrial activity, and firm demand from pharmaceutical and healthcare-related applications. Gentamicin Sulphate, an aminoglycoside antibiotic widely used in pharmaceutical formulations and veterinary medicines, remained supported by steady downstream consumption during the quarter.
Across major producing and consuming regions, rising producer prices placed upward pressure on manufacturing economics. In China, the producer price index (PPI) increased by 4.1% year-over-year in June 2026, reflecting higher costs across industrial production. Meanwhile, industrial production expanded by 5.3% year-over-year during the same month, indicating a relatively firm manufacturing environment. These factors contributed to a stronger pricing environment for Gentamicin Sulphate.
North America also witnessed an increase in the Gentamicin Sulphate Price Index during Q2 2026. In the United States, robust demand combined with higher production costs supported the upward movement. Producer prices increased by 5.5% year-over-year in June, adding to cost pressures for manufacturers.
In Europe, Germany recorded a quarter-over-quarter increase in Gentamicin Sulphate prices. The movement was primarily associated with escalating production costs, with producer prices increasing by 2.2% in May 2026.
Gentamicin Sulphate Prices in APAC
The Gentamicin Sulphate Price Index in APAC moved upward during Q2 2026, with China remaining a key market influencing regional pricing. The increase was supported by a combination of higher manufacturing costs and stronger industrial demand.
In China, Gentamicin Sulphate production costs increased during the quarter as upstream producer prices continued to rise. The country's PPI recorded a 4.1% year-over-year increase in June 2026. Higher producer prices indicated an increase in the cost environment faced by industrial manufacturers and contributed to upward pressure on pharmaceutical intermediate and active ingredient production costs.
At the same time, demand conditions improved. China's industrial production grew by 5.3% year-over-year in June 2026, reflecting stronger industrial activity. The improvement in manufacturing conditions provided support to downstream demand for pharmaceutical ingredients, including Gentamicin Sulphate.
The combination of rising production expenses and stronger demand resulted in an increase in the China Gentamicin Sulphate Price Index during Q2 2026. The current FOB price of Gentamicin Sulphate in China settled at approximately USD 94,500/MT in June 2026.
Book A Demo for Gentamicin Sulphate Prices: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Gentamicin%20Sulphate
China Gentamicin Sulphate Market Dynamics
China's position as a major pharmaceutical manufacturing hub continued to influence the regional supply chain. Gentamicin Sulphate production requires specialized pharmaceutical manufacturing processes and quality controls, meaning changes in industrial input costs can have a noticeable impact on overall production economics.
During Q2 2026, manufacturers faced a higher cost environment while industrial activity remained supportive. This combination enabled suppliers to maintain firm pricing and pass a portion of increased production expenses through the supply chain.
The increase in industrial production also indicated healthier operating conditions across China's manufacturing sector. Although Gentamicin Sulphate demand is closely linked to pharmaceutical consumption rather than general industrial production alone, broader manufacturing activity can influence operating rates, logistics, packaging, utilities, and other components of the supply chain.
Gentamicin Sulphate Prices in North America
The North American Gentamicin Sulphate Price Index increased quarter-over-quarter during Q2 2026, with the United States emerging as a key market behind the regional movement.
The increase was driven by robust demand and rising production costs. Pharmaceutical manufacturers and healthcare-related industries maintained demand for antibiotics and active pharmaceutical ingredients, providing support to the Gentamicin Sulphate market.
A major factor affecting the cost structure was the increase in US producer prices. The PPI rose by 5.5% year-over-year in June 2026, highlighting continued cost pressure across the production economy. Higher producer prices can affect manufacturers through increased expenses for raw materials, utilities, packaging, transportation, equipment, and other industrial inputs.
For Gentamicin Sulphate producers and suppliers, these higher costs contributed to a firmer pricing environment during the quarter. Suppliers faced the challenge of balancing production economics with downstream demand while maintaining pharmaceutical-grade quality and regulatory requirements.
US Demand and Supply Conditions
Demand remained an important supporting factor for Gentamicin Sulphate prices in the United States. The product continues to serve pharmaceutical applications where reliable availability and consistent quality are essential.
The US market's dependence on global pharmaceutical supply chains also means that international sourcing costs, freight conditions, inventory levels, and supplier availability can influence domestic price movements. During Q2 2026, the combination of firm demand and increased producer prices provided a supportive backdrop for Gentamicin Sulphate pricing.
While the increase in prices reflected higher costs, the market remained sensitive to changes in pharmaceutical procurement cycles. Buyers may adjust purchasing volumes depending on inventory requirements, contract structures, and expectations regarding future raw-material costs.
Gentamicin Sulphate Prices in Europe
The European Gentamicin Sulphate Price Index also recorded an increase during Q2 2026. Germany, one of Europe's important industrial and pharmaceutical markets, experienced quarter-over-quarter price growth.
The primary factor behind the increase was escalating production costs. Producer prices in Germany increased by 2.2% in May 2026, contributing to a higher cost base for manufacturers.
The European market is particularly sensitive to changes in manufacturing expenses because pharmaceutical production is subject to stringent quality, environmental, and regulatory requirements. These requirements can add to operating costs and influence the final pricing of pharmaceutical ingredients.
Germany Gentamicin Sulphate Market Outlook
Germany's Gentamicin Sulphate market remained supported by pharmaceutical demand, while higher producer prices contributed to an increase in the overall cost structure.
Manufacturers and distributors were required to manage higher production expenses while maintaining reliable supply to pharmaceutical customers. As a result, suppliers generally operated in a firmer pricing environment during the quarter.
The European market's reliance on established pharmaceutical supply chains also means that transportation costs, supplier inventories, import availability, and procurement strategies can influence price direction. However, during Q2 2026, production-cost inflation remained one of the principal factors supporting higher Gentamicin Sulphate prices in Germany.
Key Factors Influencing Gentamicin Sulphate Prices in Q2 2026
Several factors shaped the Gentamicin Sulphate market during the quarter:
Rising Production Costs
Higher producer prices were a major factor supporting the upward price movement across all three regions. China recorded a 4.1% year-over-year increase in PPI in June, while the United States recorded a 5.5% increase. Germany reported a 2.2% rise in producer prices in May.
These increases contributed to higher manufacturing expenses and strengthened the cost basis for Gentamicin Sulphate.
Stronger Industrial Activity in China
China's industrial production increased by 5.3% year-over-year in June 2026. Stronger industrial activity supported the broader manufacturing environment and contributed to firm demand conditions.
Pharmaceutical Demand
Gentamicin Sulphate remains an important pharmaceutical active ingredient, supporting demand from manufacturers of antibiotic formulations. Stable healthcare consumption and pharmaceutical procurement requirements helped maintain demand during Q2 2026.
Manufacturing Economics
Pharmaceutical-grade production requires controlled manufacturing environments, quality testing, compliance procedures, and specialized equipment. Consequently, changes in operating expenses can have a direct influence on supplier pricing.
Regional Supply Chain Conditions
Global pharmaceutical supply chains remain interconnected. Changes in production costs, inventories, transportation expenses, sourcing patterns, and supplier availability can influence regional Gentamicin Sulphate prices.
Gentamicin Sulphate Price Trend Analysis
The overall Gentamicin Sulphate price trend in Q2 2026 was bullish across the markets covered. China, the United States, and Germany all registered quarter-over-quarter increases in their respective Price Indices.
China recorded particularly firm market conditions, supported by rising production costs and stronger industrial activity. The FOB China Gentamicin Sulphate price reached USD 94,500/MT in June 2026, providing an important benchmark for regional trade.
In the United States, higher producer prices combined with robust demand contributed to the upward price movement. Meanwhile, Germany's market was affected primarily by escalating production costs, with the 2.2% increase in producer prices in May adding pressure to the cost structure.
The simultaneous increase across the three regions suggests that the Q2 2026 market environment was characterized by broad-based cost inflation rather than a single regional supply disruption.
Get Real Time Online for Gentamicin Sulphate Prices: https://www.chemanalyst.com/Pricing-data/gentamicin-sulfate-1445
Global Gentamicin Sulphate Market Outlook
Looking beyond Q2 2026, the outlook for the global Gentamicin Sulphate market will depend on the balance between pharmaceutical demand, production costs, industrial activity, and supply-chain conditions.
In China, continued industrial activity will remain an important factor for the market. If manufacturing activity remains strong, demand conditions could continue to provide support to suppliers. However, changes in producer prices and downstream procurement could influence the pace of price increases.
In the United States, the direction of producer prices will remain important. A sustained increase in manufacturing costs could keep pressure on Gentamicin Sulphate prices, while any moderation in input-cost inflation could reduce cost-driven price pressure.
For Europe, Germany's producer-price trend and pharmaceutical manufacturing activity will remain key indicators. If production expenses continue to increase, suppliers could maintain firm pricing. Conversely, improved cost conditions could reduce upward pressure.
Conclusion
The Gentamicin Sulphate Prices market experienced a broadly positive price trajectory during Q2 2026. Prices increased in APAC, North America, and Europe as manufacturers faced higher production costs alongside firm demand conditions.
China recorded a 4.1% year-over-year increase in PPI and 5.3% growth in industrial production in June 2026, supporting higher Gentamicin Sulphate prices. The China FOB price settled at approximately USD 94,500/MT in June. In the United States, a 5.5% year-over-year increase in producer prices contributed to higher production costs and supported the quarter-over-quarter increase in the Price Index. Germany also recorded an upward price movement, influenced by a 2.2% increase in producer prices in May 2026.
About Us:
Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.
Contact Us:
Address:
420 Lexington Avenue, Suite 300 New York, NY 10170 United States
Phone: +1 332 258 6602
Email: [email protected]
Website: https://www.chemanalyst.com/
LinkedIn: https://www.linkedin.com/company/chemanalyst/
Facebook: https://www.facebook.com/ChemAnalysts/
Twitter: https://x.com/chemanalysts
YouTube: https://www.youtube.com/@chemanalyst
Instagram: https://www.instagram.com/chemanalyst_
